Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)
CUSIP: 007002108
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.0001
- Shares outstanding
- 9,599,852
- Total 13F shares
- 57,126,257
- Share change
- -6,637,450
- Total reported value
- $82,259,457
- Put/Call ratio
- 160%
- Price per share
- $1.44
- Number of holders
- 62
- Value change
- -$8,520,911
- Number of buys
- 22
- Number of sells
- 49
Quarterly Holders Quick Answers
What is CUSIP 007002108?
CUSIP 007002108 identifies ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 007002108:
Top shareholders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
119%
|
11,447,140
|
$13,851,039 | — | 30 Jun 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
86%
|
8,216,960
|
$9,942,522 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
79%
|
7,541,000
|
$9,124,610 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
45%
|
4,283,372
|
$5,182,880 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
38%
|
3,621,670
|
$4,382,221 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
32%
|
3,099,956
|
$3,750,947 | — | 30 Jun 2024 | |
| Carlyle Group Inc. |
13F
|
Company |
31%
|
2,948,718
|
$3,597,436 | — | 30 Jun 2024 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
26%
|
2,531,194
|
$3,062,745 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
16%
|
1,512,600
|
$1,830,246 | — | 30 Jun 2024 | |
| Blackstone Inc. |
13F
|
Company |
13%
|
1,236,453
|
$1,496,108 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
12%
|
1,117,005
|
$1,351,576 | — | 30 Jun 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
11%
|
1,085,093
|
$1,312,000 | — | 30 Jun 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
11%
|
1,053,688
|
$1,274,962 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
11%
|
1,017,451
|
$1,231,116 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
8.7%
|
836,038
|
$1,011,606 | — | 30 Jun 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
8.3%
|
801,298
|
$969,570 | — | 30 Jun 2024 | |
| Carl L. Gordon |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
684,857
mixed-class rows
|
$941,594 | — | 21 Aug 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
8%
|
767,799
|
$929,037 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
7%
|
670,999
|
$812,145 | — | 30 Jun 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
6.8%
|
655,665
|
$793,355 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
6.6%
|
631,091
|
$763,620 | — | 30 Jun 2024 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
6.3%
|
609,446
|
$737,430 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
6.3%
|
605,139
|
$732,218 | — | 30 Jun 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
6.3%
|
600,000
|
$726,000 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
5.3%
|
513,052
|
$620,793 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
5.1%
|
486,095
|
$588,175 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
4.5%
|
429,550
|
$519,756 | — | 30 Jun 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
4.3%
|
409,049
|
$494,949 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
4.2%
|
402,541
|
$487,075 | — | 30 Jun 2024 | |
| RBF Capital, LLC |
13F
|
Company |
3.9%
|
370,000
|
$447,700 | — | 30 Jun 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
3.8%
|
364,472
|
$441,011 | — | 30 Jun 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
3.8%
|
362,230
|
$438,298 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
2.7%
|
261,896
|
$316,894 | — | 30 Jun 2024 | |
| XTX Topco Ltd |
13F
|
Company |
2.7%
|
259,788
|
$314,343 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
2.6%
|
249,357
|
$301,722 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
244,821
|
$296,233 | — | 30 Jun 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
2.2%
|
212,823
|
$257,516 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
2.2%
|
210,266
|
$254,422 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
2.2%
|
207,036
|
$250,514 | — | 30 Jun 2024 | |
| Francesco Galimi |
3/4/5
|
SVP & Chief Medical Officer |
—
mixed-class rows
|
476,878
mixed-class rows
|
$244,322 | — | 05 Jun 2024 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
2%
|
191,313
|
$231,489 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
191,300
|
$231,473 | — | 30 Jun 2024 | |
| Aya Jakobovits |
3/4/5
|
Director |
—
mixed-class rows
|
176,276
mixed-class rows
|
$214,323 | — | 21 Aug 2024 | |
| UBS Group AG |
13F
|
Company |
1.7%
|
160,835
|
$194,611 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.5%
|
147,814
|
$179,130 | — | 30 Jun 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
136,765
|
$165,485 | — | 30 Jun 2024 | |
| Alpine Global Management, LLC |
13F
|
Company |
1.2%
|
118,255
|
$143,089 | — | 30 Jun 2024 | |
| Centiva Capital, LP |
13F
|
Company |
1.1%
|
108,600
|
$131,406 | — | 30 Jun 2024 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
1.1%
|
106,008
|
$128,270 | — | 30 Jun 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.83%
|
80,036
|
$96,844 | — | 30 Jun 2024 |
Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q3 2024
As of 30 Sep 2024,
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,126,257 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, Carlyle Group Inc., Aquilo Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, and Blackstone Inc..
This page lists
63
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
83
Q3 2024 holders
62
Holder diff
-21
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.